{
    "2020-02-07": [
        [
            {
                "time": "2023-10-15",
                "original_text": "Blueprint Medicines' NDA for Avapritinib Gets Extended Review",
                "features": {
                    "keywords": [
                        "Blueprint Medicines",
                        "NDA",
                        "Avapritinib",
                        "Extended Review"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}